Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy

SIMPLE SUMMARY: We investigated the connection between the levels of 92 circulating proteins and survival in patients with advanced pancreatic ductal adenocarcinoma. Serum samples from 363 patients with advanced pancreatic ductal adenocarcinoma were examined using the Olink Immuno-Oncology panel. Tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindgaard, Sidsel C., Maag, Emil, Sztupinszki, Zsófia, Chen, Inna M., Johansen, Astrid Z., Jensen, Benny V., Bojesen, Stig E., Nielsen, Dorte L., Szallasi, Zoltan, Johansen, Julia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264968/
https://www.ncbi.nlm.nih.gov/pubmed/35805022
http://dx.doi.org/10.3390/cancers14133250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264968/
https://www.ncbi.nlm.nih.gov/pubmed/35805022
http://dx.doi.org/10.3390/cancers14133250

Ejemplares similares